LAG-3: from molecular functions to clinical applications
10.1136/jitc-2020-001014
September 13, 2020
Edited by Ana Carrizosa Anderson and Dario Vignali
Inspired by the SITC session “Immune Checkpoints – Beyond PD-1,” JITC continues the impetus of recognizing a widening range of checkpoint targets that are advancing the field forward. Comprised of several authoritative reviews of checkpoints beyond PD-1, this series promotes the tremendous research that is opening new pathways for treating patients with cancer.
10.1136/jitc-2020-001014
September 13, 2020
10.1136/jitc-2020-000957
September 7, 2020
10.1136/jitc-2020-000967
July 15, 2020
10.1136/jitc-2020-001145
July 1, 2020
10.1136/jitc-2020-000911
June 29, 2020
10.1136/jitc-2020-000695
April 8, 2020
10.1136/jitc-2019-000475
April 1, 2020
10.1136/jitc-2019-000186
February 24, 2020
10.1186/s40425-019-0761-3
December 1, 2019